Market Closed -
London S.E.
11:35:06 2024-05-31 am EDT
|
5-day change
|
1st Jan Change
|
290
GBX
|
+0.17%
|
|
-5.23%
|
+52.87%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,503
|
1,910
|
1,867
|
673.9
|
310.3
|
474.3
|
-
|
-
|
Enterprise Value (EV)
1 |
1,482
|
2,372
|
1,982
|
1,699
|
810
|
998.2
|
957.8
|
909.9
|
P/E ratio
|
16.5
x
|
642
x
|
5.34
x
|
-20.6
x
|
-2.42
x
|
-13.5
x
|
48
x
|
14.5
x
|
Yield
|
3.08%
|
2.58%
|
7.51%
|
-
|
-
|
-
|
0.74%
|
2.62%
|
Capitalization / Revenue
|
1.03
x
|
1.16
x
|
0.8
x
|
0.26
x
|
0.15
x
|
0.24
x
|
0.22
x
|
0.21
x
|
EV / Revenue
|
1.02
x
|
1.44
x
|
0.85
x
|
0.66
x
|
0.4
x
|
0.5
x
|
0.44
x
|
0.4
x
|
EV / EBITDA
|
8.33
x
|
9.15
x
|
3.79
x
|
6.41
x
|
5.82
x
|
6.08
x
|
4.72
x
|
3.88
x
|
EV / FCF
|
19.6
x
|
17.8
x
|
9.11
x
|
24.5
x
|
12.3
x
|
-31.7
x
|
21.8
x
|
20.4
x
|
FCF Yield
|
5.09%
|
5.61%
|
11%
|
4.07%
|
8.15%
|
-3.16%
|
4.59%
|
4.89%
|
Price to Book
|
2.14
x
|
3.12
x
|
1.83
x
|
0.66
x
|
0.27
x
|
0.42
x
|
0.42
x
|
0.41
x
|
Nbr of stocks (in thousands)
|
21,237
|
21,242
|
23,366
|
23,367
|
163,564
|
163,567
|
-
|
-
|
Reference price
2 |
70.76
|
89.92
|
79.92
|
28.84
|
1.897
|
2.900
|
2.900
|
2.900
|
Announcement Date
|
3/5/20
|
3/4/21
|
3/3/22
|
3/28/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,459
|
1,644
|
2,330
|
2,585
|
2,021
|
1,990
|
2,172
|
2,292
|
EBITDA
1 |
177.9
|
259.4
|
522.2
|
265.1
|
139.1
|
164.1
|
203
|
234.7
|
EBIT
1 |
125.8
|
189.6
|
450.9
|
171.2
|
37.7
|
65.92
|
106.2
|
135.5
|
Operating Margin
|
8.62%
|
11.53%
|
19.36%
|
6.62%
|
1.87%
|
3.31%
|
4.89%
|
5.91%
|
Earnings before Tax (EBT)
1 |
100.5
|
20.3
|
283.9
|
-47.6
|
-106.8
|
-26.62
|
11.04
|
36.8
|
Net income
1 |
84.6
|
3.1
|
208.7
|
-32.5
|
-67
|
-27.99
|
9.94
|
33.94
|
Net margin
|
5.8%
|
0.19%
|
8.96%
|
-1.26%
|
-3.31%
|
-1.41%
|
0.46%
|
1.48%
|
EPS
2 |
4.280
|
0.1400
|
14.98
|
-1.400
|
-0.7850
|
-0.2152
|
0.0604
|
0.2002
|
Free Cash Flow
1 |
75.5
|
133
|
217.6
|
69.2
|
66
|
-31.5
|
44
|
44.5
|
FCF margin
|
5.17%
|
8.09%
|
9.34%
|
2.68%
|
3.27%
|
-1.58%
|
2.03%
|
1.94%
|
FCF Conversion (EBITDA)
|
42.44%
|
51.27%
|
41.67%
|
26.1%
|
47.45%
|
-
|
21.67%
|
18.96%
|
FCF Conversion (Net income)
|
89.24%
|
4,290.32%
|
104.26%
|
-
|
-
|
-
|
442.63%
|
131.12%
|
Dividend per Share
2 |
2.180
|
2.320
|
6.000
|
-
|
-
|
-
|
0.0214
|
0.0760
|
Announcement Date
|
3/5/20
|
3/4/21
|
3/3/22
|
3/28/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
---|
Net sales
1 |
696.4
|
733.7
|
910.5
|
1,230
|
1,334
|
1,251
|
1,075
|
945.9
|
EBITDA
1 |
78.2
|
100.2
|
159.2
|
-
|
173.1
|
92
|
72
|
67.1
|
EBIT
1 |
51.1
|
68.6
|
121
|
-
|
132
|
-
|
23.4
|
14.3
|
Operating Margin
|
7.34%
|
9.35%
|
13.29%
|
-
|
9.89%
|
-
|
2.18%
|
1.51%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
1.740
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/5/20
|
8/6/20
|
3/4/21
|
8/5/21
|
8/2/22
|
3/28/23
|
9/7/23
|
3/12/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
462
|
114
|
1,025
|
500
|
524
|
484
|
436
|
Net Cash position
1 |
20.7
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
1.782
x
|
0.2187
x
|
3.866
x
|
3.592
x
|
3.192
x
|
2.381
x
|
1.856
x
|
Free Cash Flow
1 |
75.5
|
133
|
218
|
69.2
|
66
|
-31.5
|
44
|
44.5
|
ROE (net income / shareholders' equity)
|
15.2%
|
19.4%
|
39.8%
|
9.47%
|
-2.77%
|
0.23%
|
3.02%
|
4.72%
|
ROA (Net income/ Total Assets)
|
6.65%
|
7.41%
|
14.4%
|
-
|
-1.04%
|
0.04%
|
1.32%
|
2.29%
|
Assets
1 |
1,272
|
41.85
|
1,447
|
-
|
6,426
|
-72,255
|
752.5
|
1,483
|
Book Value Per Share
2 |
33.00
|
28.80
|
43.60
|
43.50
|
7.020
|
6.860
|
6.920
|
7.140
|
Cash Flow per Share
2 |
7.310
|
8.740
|
12.60
|
5.720
|
1.750
|
0.4800
|
0.7600
|
0.8600
|
Capex
1 |
69.1
|
53.8
|
82.2
|
90.8
|
84
|
82
|
86.7
|
90.3
|
Capex / Sales
|
4.74%
|
3.27%
|
3.53%
|
3.51%
|
4.16%
|
4.12%
|
3.99%
|
3.94%
|
Announcement Date
|
3/5/20
|
3/4/21
|
3/3/22
|
3/28/23
|
3/12/24
|
-
|
-
|
-
|
Average target price
3.031
GBP Spread / Average Target +4.52% Consensus |
1st Jan change
|
Capi.
|
---|
| +52.87% | 604M | | +17.07% | 66.31B | | -0.29% | 48.46B | | +21.61% | 43.27B | | +26.72% | 27.41B | | +9.25% | 19.26B | | -2.14% | 16.61B | | +9.75% | 16.58B | | -15.01% | 14.41B | | -30.22% | 14.02B |
Other Specialty Chemicals
|